ArticleCellular oncology (Dordrecht, Netherlands)2026

Disconnect between in vitro and in vivo efficacy of the MPS1 inhibitor NTRC 0066-0 against glioblastoma.

Mark C de Gooijer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.